Pàgina inicial > Resultats de la cerca: Moja, L.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.05 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
13 p, 396.5 KB The ecosystem of health decision making : from fragmentation to synergy / Schünemann, H.J. (Humanitas University) ; Reinap, M. (WHO Regional Office for Europe) ; Piggott, T. (McMaster University) ; Laidmäe, E. (Estonian Health Insurance Fund) ; Köhler, K. (WHO Country Office in Estonia) ; Pōld, M. (University of Tartu) ; Ens, B. (Canadian Agency for Drugs and Technology in Health) ; Irs, A. (Tartu University Hospital) ; Akl, E.A. (American University of Beirut) ; Cuello, C.A. (Canadian Agency for Drugs and Technology in Health) ; Falavigna, M. (Federal University of Rio Grande do Sul) ; Gibbens, M. (Canadian Agency for Drugs and Technology in Health) ; Neamtiu, L. (Joint Research Centre. European Commission) ; Parmelli, E. (Joint Research Centre. European Commission) ; Jameleddine, M. (National Authority for Assessment and Accreditation in Healthcare) ; Pyke, L. (Canadian Agency for Drugs and Technology in Health) ; Verstijnen, I. (National Health Care Institute) ; Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Tugwell, P. (University of Ottawa) ; Zhang, Y. (Michael G. McMaster University) ; Saz-Parkinson, Z. (Instituto de Salud Carlos III) ; Kuchenmüller, T. (WHO) ; Moja, L. (WHO) ; Universitat Autònoma de Barcelona
Clinicians, patients, policy makers, funders, programme managers, regulators, and science communities invest considerable amounts of time and energy in influencing or making decisions at various levels, using systematic reviews, health technology assessments, guideline recommendations, coverage decisions, selection of essential medicines and diagnostics, quality assurance and improvement schemes, and policy and evidence briefs. [...]
2022 - 10.1016/S2468-2667(22)00057-3
The Lancet public health, Vol. 7 Núm. 4 (april 2022) , p. e378-e390  
Registre complet - Creative Commons
2.
9 p, 1.2 MB Which actionable statements qualify as good practice statements In Covid-19 guidelines? A systematic appraisal / Dewidar, Omar (School of Epidemiology and Public Health. University of Ottawa) ; Lotfi, Tamara (Who Collaborating Center for Infectious Diseases. Research Methods and Recommendations. McMaster University) ; Langendam, Miranda (Amsterdam University Medical Centers. University of Amsterdam) ; Parmelli, Elena (Joint Research Centre. European Commission) ; Saz Parkinson, Zuleika (Instituto de Salud Carlos Iii. Agencia de Evaluación de Tecnologías Sanitarias) ; Solo, Karla (Who Collaborating Center for Infectious Diseases. Research Methods and Recommendations. McMaster University) ; Chu, Derek K. (Department of Medicine. McMaster University) ; Mathew, Joseph L. (Department of Pediatrics. Post Graduate Institute of Medical Education and Research) ; Akl, Eli A. (Department of Internal Medicine. American University of Beirut) ; Brignardello-Petersen, Romina (Michael G DeGroote Cochrane Canada and McMaster Grade Centres. McMaster University) ; Mustafa, Reem A. (Internal Medicine. Division of Nephrology and Hypertension. University of Kansas School of Medicine) ; Moja, Lorenzo (Department of Health Product Policy and Standards. World Health Organization) ; Iorio, Alfonso (Department of Medicine. McMaster University) ; Chi, Yuan (Cochrane Campbell Global Ageing Partnership) ; Canelo Aybar, Carlos Gilberto (Institut d'Investigació Biomèdica Sant Pau) ; Kredo, Tamara (Clinical Pharmacology. Department of Medicine. Stellenbosch University) ; Karpusheff, Justine (National Institute for Health and Care Excellence) ; Turgeon, Alexis F. (Department of Anesthesiology and Critical Care Medicine. Université Laval) ; Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Wiercioch, Wojtek (Who Collaborating Center for Infectious Diseases. Research Methods and Recommendations. McMaster University) ; Gerritsen, Annette (Cochrane South Africa. South African Medical Research Council) ; Klugar, Miloslav (Czech National Centre for Evidence-Based Healthcare and Knowledge Translation. Institute of Biostatistics and Analyses. Masaryk University) ; Rojas-Reyes, Maria Ximena (Institut d'Investigació Biomèdica Sant Pau) ; Tugwell, Peter (Clinical Epidemiology Program. Ottawa Hospital Research Institute) ; Welch, Vivian (School of Epidemiology and Public Health. University of Ottawa) ; Pottie, Kevin (Deparatment of Family Medicine. University of Ottawa) ; Munn, Zachary (Joanna Briggs Institute. University of Adelaide) ; Nieuwlaat, Robby (Department of Health Research Methods Evidence and Impact. McMaster University) ; Ford, Nathan (Department of Hiv. Hepatitis and Sexually Transmitted Infections. World Health Organization) ; Stevens, Adrienne (Michael G DeGroote Cochrane Canada and McMaster Grade Centres. McMaster University) ; Khabsa, Joanne (Clinical Research Institute. American University of Beirut) ; Nasir, Zil (Michael G DeGroote Cochrane Canada and McMaster Grade Centres. McMaster University) ; Leontiadis, Grigorios I. (Department of Medicine. McMaster University) ; Meerpohl, Joerg J. (Medical Center - University of Freiburg. Institute for Evidence in Medicine) ; Piggott, Thomas (Who Collaborating Center for Infectious Diseases. Research Methods and Recommendations. McMaster University) ; Qaseem, Amir (American College of Physicians) ; Matthews, Micayla (McMaster University (Canadà)) ; Schünemann, Holger (Cochrane Canada)
Objectives To evaluate the development and quality of actionable statements that qualify as good practice statements (GPS) reported in COVID-19 guidelines. Design and setting Systematic review. We searched MEDLINE, MedSci, China National Knowledge Infrastructure (CNKI), databases of Grading of Recommendations Assessment, Development and Evaluation (GRADE) Guidelines, NICE, WHO and Guidelines International Network (GIN) from March 2020 to September 2021. [...]
2022 - 10.1136/bmjebm-2021-111866
BMJ Evidence-Based Medicine, Vol. 27 Núm. 6 (April 2022) , p. 361-369  
Registre complet - Creative Commons
3.
7 p, 364.6 KB The "Square Box" : Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines / Cappello, Bernadette (Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland) ; Moja, Lorenzo (Department of Health Products Policy and Standards, World Health Organization, Geneva, Switzerland) ; Figueras, Albert 1961- (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Magrini, Nicola (Italian Medicines Agency, Rome)
Every two years, the World Health Organization (WHO) updates its Model List of Essential Medicines, intended as a guide for countries to adopt or adapt in accordance with local priorities and treatment guidelines, for the development of national essential medicines lists. [...]
2020 - 10.3389/fphar.2020.578000
Frontiers in Pharmacology, Vol. 11 (september 2020)  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
2 Moja, Lorenzo
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem